Integrated Screening for Down's Syndrome

New England Journal of Medicine

Volumn 341, Issue 25, 1999, Pages 1935-

  Jenkins, Thomas M ^a   Wapner, Ronald J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33748251878     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199912163412513     Document Type: Article

References (4)

1. Wald N), Watt HC, Hackshaw AK. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. N Engl J Med 1999;341:461-7.
2. Canadian Collaborative CVS-Amniocentesis Clinical Trial Group. Multicentre randomised clinical trial of chorion villus sampling and amniocentesis. Lancet 1989;l:l-6.
3. Rhoads GG, Jackson LG, Schlessclman SE, et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic ab normalities. N Engl J Med I989;320:609-17.
4. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. A screen ing program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999;13: 231 7.